Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-07-037233
Filing Date
2007-06-15
Accepted
2007-06-15 13:52:42
Documents
2
Period of Report
2007-05-10

Document Format Files

Seq Description Document Type Size
1 MAIN DOCUMENT DESCRIPTION bdn47588_bdn1ce.html 4  
1 MAIN DOCUMENT DESCRIPTION bdn47588_bdn1ce.xml 4 4153
2 POWER OF ATTORNEY d47588ce.txt EX-24 3958
  Complete submission text file 0001209191-07-037233.txt   9870
Mailing Address 1450 INFINITE DRIVE LOUISVILLE CO 80027
Business Address 1450 INFINITE DRIVE LOUISVILLE CO 80027 303-665-3450
REPLIDYNE INC (Issuer) CIK: 0001180145 (see all company filings)

EIN.: 841568247 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2099 PENNSYLVANIA AVE NW STE 900 WASHINGTON DC 20006-1813
Business Address
EARL CHRISTOPHER (Reporting) CIK: 0001250197 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-52082 | Film No.: 07922412